Clinical Trial Update: Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial from Shandong University is evaluating the safety and potential efficacy of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Shandong University | Conditions: Type 2 Diabetes | Phase 1, Phase 2 | Status: UNKNOWN